PT  - JOURNAL ARTICLE
AU  - Du, Zhanwei
AU  - Wang, Lin
AU  - Cauchemez, Simon
AU  - Xu, Xiaoke
AU  - Wang, Xianwen
AU  - Cowling, Benjamin J.
AU  - Meyers, Lauren Ancel
TI  - Risk of 2019 novel coronavirus importations throughout China prior to the Wuhan quarantine
AID  - 10.1101/2020.01.28.20019299
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.01.28.20019299
4099  - http://medrxiv.org/content/early/2020/01/30/2020.01.28.20019299.short
4100  - http://medrxiv.org/content/early/2020/01/30/2020.01.28.20019299.full
AB  - On January 23, 2020, China enacted a travel quarantine of Wuhan and nearby cities to curb the geographic expansion of a novel coronavirus (2019-nCoV). Here, we use ground, rail and air travel data to estimate the probability that 2019-nCoV cases were imported from Wuhan to 370 cities throughout China in the three weeks prior to the quarantine. Based on an estimated R0 of 2.56 [95% CI: 2.09, 2.78], we find that the probability of a pre-quarantine introduction exceeds 50% in 131 [95% CI 72, 232] cities, including six cities with populations over two million people with no reported cases as of January 27th.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge the financial support from NIH (U01 GM087719), the Investissement d’Avenir program, the Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases program (Grant ANR-10-LABX-62-IBEID) and European Union V.E.O project. None of the authors or their institutions at any time received payment or services from a third party for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will become available upon publication in a peer-reviewed journal.